InsidersTradesSigma
Follow the Diamyd Medical AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Diamyd Medical AB has logged 7 reports. Market capitalisation: €159.9m. The latest transaction was filed on 24 June 2026 (Purchase). Among the most active insiders: Anders Essen-Möller. Every trade is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€596,975
7 ops.
Buy Volume
n/a
n/a
Sell Volume
47Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 June 2026
Declarations7 total
100,000 shares@ SEK 1.000.0059% mcap1.6% of flowAktieISIN SE0005162880FI:csv-c0583c028b9c2148656e
200,000 shares@ €0.09670.012% mcap100.0% of flowAktieISIN SE0020997468FI:A003X890-1
1,000 shares@ €0.90490.0005% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N869-1
1,020 shares@ €0.72770.0004% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N791-1
327,124 shares@ €0.73150.14% mcap42.9% of flowBTU (betald tecknad unit)ISIN SE0022760336FI:A003N796-1
435,630 shares@ €0.73150.19% mcap57.1% of flowBTU (betald tecknad unit)ISIN SE0005162880FI:A003N795-1
12,500 shares@ €0.72770.0055% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N704-1
7 of 7 declarations
关于 Diamyd Medical AB
Diamyd Medical AB 是一家瑞典生物制药公司，专注于开发1型糖尿病的治疗方法。该公司专门从事基于重组蛋白的创新疗法。